======= ADAMTS18 ======= == Gene Information == * **Official Symbol**: ADAMTS18 * **Official Name**: ADAM metallopeptidase with thrombospondin type 1 motif 18 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=170692|170692]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8TE60|Q8TE60]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ADAMTS18&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ADAMTS18|Open PubMed]] * **OMIM**: [[https://omim.org/entry/607512|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. ADAMTS family members share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The encoded preproprotein is proteolytically processed to generate the mature protein, which may regulate hemostatic balance and function as a tumor suppressor. Mutations in this gene may be associated with microcornea, myopic chorioretinal atrophy, and telecanthus (MMCAT) and cone-rod dystrophy in human patients. [provided by RefSeq, May 2016]. * **UniProt Summary**: N/A |PLAC| |Pep M12B propep| |ADAM spacer1| |Reprolysin| |TSP 1| |negative regulation of platelet aggregation| |negative regulation of homotypic cell-cell adhesion| |regulation of platelet aggregation| |negative regulation of platelet activation| |regulation of homotypic cell-cell adhesion| |regulation of platelet activation| |negative regulation of blood coagulation| |negative regulation of hemostasis| |negative regulation of coagulation| |negative regulation of wound healing| |regulation of blood coagulation| |regulation of hemostasis| |regulation of coagulation| |negative regulation of response to wounding| |metalloendopeptidase activity| |regulation of wound healing| |regulation of response to wounding| |negative regulation of cell-cell adhesion| |negative regulation of cell activation| |negative regulation of cell adhesion| |eye development| |visual system development| |negative regulation of response to external stimulus| |sensory system development| |regulation of cell-cell adhesion| |regulation of body fluid levels| |sensory organ development| |regulation of cell activation| |regulation of cell adhesion| |regulation of response to external stimulus| |negative regulation of multicellular organismal process| |proteolysis| |regulation of response to stress| |negative regulation of response to stimulus| |extracellular region| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp129|Isonicotinamide 500μM R03 exp129]]|-1.85| |[[:results:exp374|Latrunculin-B 10μM R07 exp374]]|-1.72| |[[:results:exp71|KU-0063794 3.8μM R02 exp71]]|1.74| |[[:results:exp351|Dexamethasone 0.006μM R07 exp351]]|1.79| |[[:results:exp483|FTY720 3μM R08 exp483]]|1.88| |[[:results:exp417|Tubastatin-A 2.5μM R07 exp417]]|2.37| ^Gene^Correlation^ |[[:human genes:p:prim1|PRIM1]]|0.419| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 5449 * **Expression level (log2 read counts)**: 1.02 {{:chemogenomics:nalm6 dist.png?nolink |}}